Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Kirk

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
JACC. Basic to Translational Science|October 4, 2023
Going Further With Half as Much: It's in the BAGJonathan A Kirk
JACC. Basic to Translational Science|December 2, 2024
When Off-Target <i>Is</i> the Target: Treating Noncardiomyocytes in Cardiac LaminopathyJonathan A Kirk
Antioxidants & Redox Signaling|September 12, 2014
New redox-related arrows in the arsenal of cardiac disease treatmentJonathan A Kirk, Nazareno Paolocci
Circulation Research|August 31, 2013
Electromechanical dyssynchrony and resynchronization of the failing heartJonathan A Kirk, David A Kass
Heart Failure Clinics|November 26, 2016
Cellular and Molecular Aspects of Dyssynchrony and ResynchronizationJonathan A Kirk, David A Kass
Vitamins and Hormones|July 12, 2024
Glycation in the cardiomyocyteChristine E Delligatti, Jonathan A Kirk
Journal of Molecular and Cellular Cardiology|September 13, 2020
Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomereThomas G Martin, Jonathan A Kirk
Cardiac Electrophysiology Clinics|November 25, 2015
Cellular and Molecular Aspects of Dyssynchrony and ResynchronizationJonathan A Kirk, David A Kass
American Journal of Physiology. Heart and Circulatory Physiology|March 3, 2018
Galectin-3 in the pathogenesis of heart failure: a causative mediator or simply a biomarker?Jonathan A Kirk, Nikolaos G Frangogiannis
Journal of Molecular and Cellular Cardiology|December 22, 2015
Thrombospondins in the transition from myocardial infarction to heart failureJonathan A Kirk, Oscar H Cingolani
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
JACC. Basic to Translational Science|October 4, 2023
Going Further With Half as Much: It's in the BAGJonathan A Kirk
JACC. Basic to Translational Science|December 2, 2024
When Off-Target <i>Is</i> the Target: Treating Noncardiomyocytes in Cardiac LaminopathyJonathan A Kirk
Antioxidants & Redox Signaling|September 12, 2014
New redox-related arrows in the arsenal of cardiac disease treatmentJonathan A Kirk, Nazareno Paolocci
Circulation Research|August 31, 2013
Electromechanical dyssynchrony and resynchronization of the failing heartJonathan A Kirk, David A Kass
Heart Failure Clinics|November 26, 2016
Cellular and Molecular Aspects of Dyssynchrony and ResynchronizationJonathan A Kirk, David A Kass
Vitamins and Hormones|July 12, 2024
Glycation in the cardiomyocyteChristine E Delligatti, Jonathan A Kirk
Journal of Molecular and Cellular Cardiology|September 13, 2020
Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomereThomas G Martin, Jonathan A Kirk
Cardiac Electrophysiology Clinics|November 25, 2015
Cellular and Molecular Aspects of Dyssynchrony and ResynchronizationJonathan A Kirk, David A Kass
American Journal of Physiology. Heart and Circulatory Physiology|March 3, 2018
Galectin-3 in the pathogenesis of heart failure: a causative mediator or simply a biomarker?Jonathan A Kirk, Nikolaos G Frangogiannis
Journal of Molecular and Cellular Cardiology|December 22, 2015
Thrombospondins in the transition from myocardial infarction to heart failureJonathan A Kirk, Oscar H Cingolani
Pageof 8